Golnaz Eftekhari Yazdi

424 total citations
14 papers, 289 citations indexed

About

Golnaz Eftekhari Yazdi is a scholar working on Epidemiology, Hepatology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Golnaz Eftekhari Yazdi has authored 14 papers receiving a total of 289 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 8 papers in Hepatology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Golnaz Eftekhari Yazdi's work include Hepatitis C virus research (8 papers), Liver Disease Diagnosis and Treatment (5 papers) and Hepatitis B Virus Studies (5 papers). Golnaz Eftekhari Yazdi is often cited by papers focused on Hepatitis C virus research (8 papers), Liver Disease Diagnosis and Treatment (5 papers) and Hepatitis B Virus Studies (5 papers). Golnaz Eftekhari Yazdi collaborates with scholars based in United States, New Zealand and Kenya. Golnaz Eftekhari Yazdi's co-authors include Benjamin P. Linas, Joshua A. Barocas, Jianing Wang, Joshua A. Salomon, Claudia Vellozzi, Liisa M. Randall, Sabrina A. Assoumou, Alexandra Savinkina, Rachel Epstein and Jake R. Morgan and has published in prestigious journals such as Clinical Infectious Diseases, American Journal of Epidemiology and The American Journal of Medicine.

In The Last Decade

Golnaz Eftekhari Yazdi

14 papers receiving 281 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Golnaz Eftekhari Yazdi United States 9 219 134 97 46 22 14 289
Laura Morciano Italy 7 103 0.5× 20 0.1× 44 0.5× 13 0.3× 55 2.5× 10 231
Lu Y. Hwang United States 7 213 1.0× 155 1.2× 15 0.2× 80 1.7× 24 1.1× 9 298
Sofía Ibarra Spain 11 59 0.3× 29 0.2× 21 0.2× 155 3.4× 32 1.5× 20 309
Abdulaziz Bako United States 8 62 0.3× 15 0.1× 28 0.3× 46 1.0× 23 1.0× 32 191
Jacqueline A. Richmond Australia 11 220 1.0× 207 1.5× 15 0.2× 48 1.0× 37 1.7× 30 316
Marianne Alanko Blomé Sweden 9 141 0.6× 60 0.4× 59 0.6× 37 0.8× 10 0.5× 17 177
Robert Spears United States 9 140 0.6× 106 0.8× 12 0.1× 39 0.8× 12 0.5× 17 306
Galina Moskaleva United States 7 144 0.7× 9 0.1× 33 0.3× 175 3.8× 15 0.7× 8 323
Fenella Beynon United Kingdom 8 111 0.5× 41 0.3× 13 0.1× 81 1.8× 33 1.5× 14 206
Donald Gardenier United States 9 146 0.7× 140 1.0× 18 0.2× 60 1.3× 57 2.6× 62 246

Countries citing papers authored by Golnaz Eftekhari Yazdi

Since Specialization
Citations

This map shows the geographic impact of Golnaz Eftekhari Yazdi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Golnaz Eftekhari Yazdi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Golnaz Eftekhari Yazdi more than expected).

Fields of papers citing papers by Golnaz Eftekhari Yazdi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Golnaz Eftekhari Yazdi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Golnaz Eftekhari Yazdi. The network helps show where Golnaz Eftekhari Yazdi may publish in the future.

Co-authorship network of co-authors of Golnaz Eftekhari Yazdi

This figure shows the co-authorship network connecting the top 25 collaborators of Golnaz Eftekhari Yazdi. A scholar is included among the top collaborators of Golnaz Eftekhari Yazdi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Golnaz Eftekhari Yazdi. Golnaz Eftekhari Yazdi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Zhu, Lin, Jennifer R. Havens, Abby E. Rudolph, et al.. (2025). Hepatitis C virus transmission among people who inject drugs in rural United States: mathematical modeling study using stochastic agent-based network simulation. American Journal of Epidemiology. 2 indexed citations
2.
3.
Brandeau, Margaret L., Golnaz Eftekhari Yazdi, Jianing Wang, et al.. (2022). Metamodeling for Policy Simulations with Multivariate Outcomes. Medical Decision Making. 42(7). 872–884. 7 indexed citations
4.
Linas, Benjamin P., Alexandra Savinkina, R. W. M. A. Madushani, et al.. (2021). Projected Estimates of Opioid Mortality After Community-Level Interventions. JAMA Network Open. 4(2). e2037259–e2037259. 41 indexed citations
5.
Assoumou, Sabrina A., Jianing Wang, Golnaz Eftekhari Yazdi, et al.. (2020). HCV Testing and Treatment in a National Sample of US Federally Qualified Health Centers during the Opioid Epidemic. Journal of General Internal Medicine. 35(5). 1477–1483. 14 indexed citations
6.
Assoumou, Sabrina A., Liesl M. Hagan, Jianing Wang, et al.. (2020). Hepatitis C Management at Federally Qualified Health Centers during the Opioid Epidemic: A Cost-Effectiveness Study. The American Journal of Medicine. 133(11). e641–e658. 5 indexed citations
7.
Barocas, Joshua A., Golnaz Eftekhari Yazdi, Alexandra Savinkina, et al.. (2020). Long-term Infective Endocarditis Mortality Associated With Injection Opioid Use in the United States: A Modeling Study. Clinical Infectious Diseases. 73(11). e3661–e3669. 43 indexed citations
8.
Yazdi, Golnaz Eftekhari, Sarah Schillie, Claudia Vellozzi, et al.. (2019). Short-Term Effects and Long-Term Cost-Effectiveness of Universal Hepatitis C Testing in Prenatal Care. Obstetrics and Gynecology. 133(2). 289–300. 34 indexed citations
9.
Barocas, Joshua A., Jake R. Morgan, David A. Fiellin, et al.. (2019). Cost-effectiveness of integrating buprenorphine-naloxone treatment for opioid use disorder into clinical care for persons with HIV/hepatitis C co-infection who inject opioids. International Journal of Drug Policy. 72. 160–168. 25 indexed citations
10.
Assoumou, Sabrina A., Claudia Vellozzi, Golnaz Eftekhari Yazdi, et al.. (2019). Cost-effectiveness and Budgetary Impact of Hepatitis C Virus Testing, Treatment, and Linkage to Care in US Prisons. Clinical Infectious Diseases. 70(7). 1388–1396. 24 indexed citations
11.
Barocas, Joshua A., Golnaz Eftekhari Yazdi, Jianing Wang, et al.. (2018). Population-level Outcomes and Cost-Effectiveness of Expanding the Recommendation for Age-based Hepatitis C Testing in the United States. Clinical Infectious Diseases. 67(4). 549–556. 48 indexed citations
12.
Yazdi, Golnaz Eftekhari, et al.. (2018). An Adaptive Proportional BCI-Controller for Linear Dynamic Systems. 1–5. 2 indexed citations
13.
Assoumou, Sabrina A., Jianing Wang, Golnaz Eftekhari Yazdi, et al.. (2018). Hepatitis C Testing and Patient Characteristics in Washington State's Prisons Between 2012 and 2016. American Journal of Preventive Medicine. 56(1). 8–16. 10 indexed citations
14.
Farquhar, Cindy, et al.. (2002). A prospective study of the short‐term outcomes of hysterectomy with and without oophorectomy. Australian and New Zealand Journal of Obstetrics and Gynaecology. 42(2). 197–204. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026